Skip to Main Content

Author Details

Vladimir Ignatchenko
Margaret Cancer Center
2009
44
24
PMIDPaper TitleJournal TitlePublished Year
36508580Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects.J Proteome Res2023
37546794Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes.bioRxiv2023
37872586Correction to: Dynamic profiling of medulloblastoma surfaceome.Acta Neuropathol Commun2023
37430373Dynamic profiling of medulloblastoma surfaceome.Acta Neuropathol Commun2023
35981243Glycoproteomics Identifies Plexin-B3 as a Targetable Cell Surface Protein Required for the Growth and Invasion of Triple-Negative Breast Cancer Cells.J Proteome Res2022
35505417Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena.J Hematol Oncol2022
36671461Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes.Biomolecules2022
36178522The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.Acta Neuropathol2022
34031589Mammary epithelial cells have lineage-rooted metabolic identities.Nat Metab2021
33793244Rat Sciatic Nerve Axoplasm Proteome Is Enriched with Ribosomal Proteins during Regeneration Processes.J Proteome Res2021
33568753Functionally selective activation of the dopamine receptor D<sub>2</sub> is mirrored by the protein expression profiles.Sci Rep2021
34152685A proteomic investigation of isogenic radiation resistant prostate cancer cell lines.Proteomics Clin Appl2021
30889379The Proteogenomic Landscape of Curable Prostate Cancer.Cancer Cell2019
30981729N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer.Cell Syst2019
29264800Proteomic Profiling of Secreted Proteins, Exosomes, and Microvesicles in Cell Culture Conditioned Media.Methods Mol Biol2018
29681158Proteomic Analysis of Cancer-Associated Fibroblasts Reveals a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma.J Proteome Res2018
27750381Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.Int J Cancer2017
28716134Detecting protein variants by mass spectrometry: a comprehensive study in cancer cell-lines.Genome Med2017
28921918Proteomic Response of Human Umbilical Vein Endothelial Cells to Histamine Stimulation.Proteomics2017
27350604Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.Nat Commun2016
27424784Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors.Cell Stem Cell2016
25545689VennDIS: a JavaFX-based Venn and Euler diagram software to generate publication quality figures.Proteomics2015
26247883A Genome Scale Screen for Mutants with Delayed Exit from Mitosis: Ire1-Independent Induction of Autophagy Integrates ER Homeostasis into Mitotic Lifespan.PLoS Genet2015
26403541Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function.Nat Commun2015
25784717CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration.Mol Cancer Res2015
24453208Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches.Proteomics2014
25429762Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.Nat Commun2014
25271301Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway.Mol Cell Proteomics2014
25146974Global proteome analysis identifies active immunoproteasome subunits in human platelets.Mol Cell Proteomics2014
24434149In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.Biochem Biophys Res Commun2014
22339264Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.J Proteome Res2012
22986220Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.Mol Cell Proteomics2012
23144632A combination of H2A.Z and H4 acetylation recruits Brd2 to chromatin during transcriptional activation.PLoS Genet2012
22918226Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.Mol Cell Proteomics2012
22653920Proteomic profiling of the planarian Schmidtea mediterranea and its mucous reveals similarities with human secretions and those predicted for parasitic flatworms.Mol Cell Proteomics2012
22424930Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells.Dev Cell2012
20815376Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.J Proteome Res2011
21986993Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia.Mol Cell Proteomics2011
21491939In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.J Proteome Res2011
21246116Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis.Mol Biosyst2011
20334419In-depth proteomic analyses of direct expressed prostatic secretions.J Proteome Res2010
20634894Endoplasmic reticulum protein targeting of phospholamban: a common role for an N-terminal di-arginine motif in ER retention?PLoS One2010
19536202Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology.Mol Syst Biol2009
19670906Peptide separations by on-line MudPIT compared to isoelectric focusing in an off-gel format: application to a membrane-enriched fraction from C2C12 mouse skeletal muscle cells.J Proteome Res2009
  • 1 - 44 of 44

Recommended Authors

University of Wisconsin-Madison
Career Start Year 2015
Number of shared co-authors 0
British Columbia Cancer Research Institute
Career Start Year 2013
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2013
Number of shared co-authors 1
Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Career Start Year 2011
Number of shared co-authors 0
Quantitative Biosciences Institute (QBI), University of California san francisco
Career Start Year 2009
Number of shared co-authors 0
Uppsala University
Career Start Year 2008
Number of shared co-authors 1
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 2
Yale University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Career Start Year 2006
Number of shared co-authors 1
Pacific Northwest National Laboratory
Career Start Year 2006
Number of shared co-authors 0
Yonsei University
Career Start Year 2005
Number of shared co-authors 1
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 0
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year 2004
Number of shared co-authors 3
Howard Hughes Medical Institute, University of California San Diego
Career Start Year 2003
Number of shared co-authors 0
Stanford University
Career Start Year 2003
Number of shared co-authors 3
University College Dublin
Career Start Year 2002
Number of shared co-authors 0
Universitatsklinikum
Career Start Year 2002
Number of shared co-authors 1
Pacific Northwest National Laboratory
Career Start Year 2000
Number of shared co-authors 0
Institute of Molecular and Cell Biology
Career Start Year 2000
Number of shared co-authors 0
Stanford University
Career Start Year 2000
Number of shared co-authors 2
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Career Start Year 2000
Number of shared co-authors 0
Tel Aviv University
Career Start Year 2000
Number of shared co-authors 1
Pacific Northwest National Laboratory
Career Start Year 1998
Number of shared co-authors 0
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1998
Number of shared co-authors 6
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1991
Number of shared co-authors 6
Max-Planck Institute of Biochemistry
Career Start Year 1989
Number of shared co-authors 4
Institute for Systems Genetics, NYU Grossman School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 1988
Number of shared co-authors 3

Collaborators

Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 44
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 12
University of California los angeles
Co-authored papers 12
Max Planck Institute of Biochemistry
Co-authored papers 10
University of Toronto, University Avenue
Co-authored papers 9
Margaret Cancer Center
Co-authored papers 6
Hospital for Sick Children, University of Toronto
Co-authored papers 6
Hospital for Sick Children
Co-authored papers 6
Eastern Virginia Medical School
Co-authored papers 5
Rosalind and Morris Goodman Cancer Institute, McGill University
Co-authored papers 5
University Health Network, University of Toronto
Co-authored papers 5
Washington State University Elson S. Floyd College of Medicine
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Eastern Virginia Medical School
Co-authored papers 5
Hospital for Sick Children
Co-authored papers 4
University of Toronto
Co-authored papers 4
Medical University of South Carolina
Co-authored papers 4
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 4
Hospital for Sick Children
Co-authored papers 4
Schroeder Arthritis Institute
Co-authored papers 4
Princess Margaret Cancer Center, University Health Network
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 3
University of Toronto
Co-authored papers 3
International Centre for Cancer Vaccine Science, University of Gdansk
Co-authored papers 3
Eastern Virginia Medical School
Co-authored papers 3
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 3
Princess Margaret Cancer Centre
Co-authored papers 3
McMaster Stem Cell and Cancer Research Institute
Co-authored papers 3
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 3